• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2000 Fiscal Year Final Research Report Summary

ANALYSIS OF CLASS II MHC DERIVED ANTIGENIC PEPTIDES FROM HUMAN INTESTINE

Research Project

Project/Area Number 09670565
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionTHIRD DEPARTMENT OF INTERNAL MEDICINE, OSAKA CITY UNIVERSITY MEDICAL SCHOOL

Principal Investigator

OSHITANI Nobuhide  OSAKA CITY UNIVERSITY MEDICAL SCHOOL, THIRD DEPARTMENT OF INTERNAL MEDICINE LECTURER, 医学部, 講師 (20231235)

Co-Investigator(Kenkyū-buntansha) HATO Fumihiko  OSAKA CITY UNIVERSITY MEDICAL SCHOOL, SECOND DEPARTMENT OF PHYSIOLOGY, ASSOCIATE PROFESSOR, 医学部, 助教授 (00198772)
Project Period (FY) 1997 – 2000
KeywordsCLASS II MHC / HLA-DR / ANTIGENIC PEPTIDE / CROHN'S DISEASE / ULCERATIVE COLITIS / TANDEM-MASS ANALYSIS / MASS ANALYSIS
Research Abstract

The specific antigen responsible for the pathogenesis of inflammatory bowel disease is unknown. We isolated HLA-DR-associated peptides from human intestine and sequenced their amino-acid residues by ion-trap tandem mass spectrometry equipped with online reverse-phase high performance liquid chromatography. Serum antibody titers against two of the above determined antigens were measured. We detected 73 parent proteins from 4 controls, 10 patients with ulcerative colitis, and 10 patients with Crohn's disease. The calculated molecular masses (m/z) of these peptides ranged from 582.2 to 2988.5, representing 7 to 27 amino acid residues. Sixty-eight of these 73 parent proteins were exogenous proteins. Neither MHC nor invariant chain-derived peptides were found among human intestinal class II MHC-associated peptides, contrary to previous findings for transformed cells. Escherichia coli-, Saccharomyces cerevisiae-, and Caenorhabditis elegans-derived peptides were found veryfrequently in patients with inflammatory bowel disease. Serum antibody titers against S.cerevisiae and C.elegans were measured, and were significantly higher in patients with inflammatory bowel disease than in controls. The present results suggest that in vivo antigen processing by antigen-presenting cells and T lymphocytes in human intestine are participated with exogenous antigen presentation. Increased immune responses against S.cerevisiae and C.elegans were found in patients with inflammatory bowel and may participate as dysregulated immune responses to enteric flora in the pathogenesis of inflammatory bowel disease.

  • Research Products

    (13 results)

All Other

All Publications (13 results)

  • [Publications] OSHITANI N. et al: "Functional and phenotypical activation of leukocytes in inflamed human colonic mucosa"J.Gastroenterol Hepatol. 12. 809-814 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] OSHITANI N. et al: "Functional diversity of infiltrating macrophages in inflamed human colonic mucosa"Clin Exp Pharmacol Physiol. 25. 50-53 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kakazu T. et al: "Type 1 helper-cell predominance in granuloma of crohn's disease"Am J Gastroenterol. 94. 2149-2155 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] OSHITANI N. et al: "Down-regulation by bucillamine of lamina propria leukocytes in rat colitis model"Clin Exp Pharmacol Physiol. 26. 956-958 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] OSHITANI N. et al: "Decreased anti-Saccharomyces cerevisiae antibody titer by mesalazine in patients with Crohn's disease"J Gastroenterol Hepatol. 15. 1400-1403 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Oshitani N. et al: "Heterogeneity of HPLC Protiles of human class II MHC-bound peptides isolated from in testine with inflammatory bound disease"Dig Dis Sci. (in press).

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Oshitani N, Sawa Y, Hara J, Adachi K, Nakamura S, Matsumoto T, Arakawa T, Kuroki T.: "Functional and phenotypical activation of leukocytes in inflamed human colonic mucosa."J.Gastroenterol.Hepatol. 12. 809-814 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Oshitani N, Kitano A, Kakazu T, Hara J, Adachi K, Nakamura S, Matsumoto T, Kobayashi K.: "Functional diversity of infiltrating macrophages in inflamed human colonic mucosa."Clin.Exp.Pharmacol.Physiol.. 25. 50-53 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kakazu T, Ha ra J, Matsumoto T, Nakamura S, Oshitani N, Arakawa T, Kitano A, Nakatani K, Kinjo F, Kuroki T.: "Type 1 T-helper cell predominance in granulomas of Crhon's disease."Am.J.Gastroenterology.. 94. 2149-2155 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Oshitani N, Matsumoto T, Nakamura S, Arakawa T, Kitano A, Kuroki T.: "Down-regulation by bucillamine of lamina propria leukocytes in rat colitis model."Clin.Exp.Pharmacol.Physiol.. 26. 956-958 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Oshitani N, Hato F, Matsumoto T, Jinno Y, Sawa Y, Hara J, Nakamura S, Seki S, Arakawa T, Kitano A, Kitagawa S, Kuroki T.: "Decreased anti-Saccharomyces cerevisiae antibody titer by mesalazine in patients with Crohn's disease."J Gastroenterol Hepatol. 15. 1400-1403 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Oshitani N, Hato, Jinno Y, Sawa Y, Hara J, Nakamura S, Matsumoto T, Arakawa T, Kitano A, Kitagawa S, Kuroki T.: "Heterogeneity of HPLC profiles of human class II MHC-bound peptides isolated from intestine with inflammatory bowel disease"Dig.Dis.Sce.. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] N.Oshitani, F.Hato, Y.Jinno, Y.Sawa, S.Nakamura, T.Matsumoto, S.Seki, T.Arakawa, S.Kitagawa.: "IgG subclasses of anti Saccharomyces cerevisiae antibody in inflammatoby bowel disease."Eur J Clin Invest. (in press).

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2002-03-26  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi